DHC Live Virtual Summit Series

Hosted by The DHC Group and Novartis

September 30 & October 1
12PM - 1:30PM EDT

About the September Virtual Summit

The DHC Group and Novartis are excited to bring you dynamic content and thought leadership related to the opportunities and challenges of the new normal. Topics covered include the new realities of a virtual launch, latest research on physician preferences, social media trends, and a look at the new normal for HCP communications.

The event will span two days, lasting just 90 minutes per day, and feature unique content each day. Registration automatically covers both days, and you will be sent agenda updates and calendar reminders.

Featured Speakers

Ozgun Demir
Director, Digital Strategy
Novartis
Connect on LinkedIN

Dr. Gautam Gulati
Status Quo Agitator and Innovation Speaker
Connect on LinkedIN

Belen Fraile,
VP and Head, US Oncology Data and Digital, Novartis Oncology
Connect on LinkedIN

Matt Walsh
Senior Director, Solutions Engineering, Crossix
Connect on LinkedIN

Content Themes

Agenda

DAY ONE

September 30th
12:00 – 1:30pm edt

WELCOME (DHC Group + Novartis)

Succeeding at Virtual Brand Launch – A Case Study
Ozgun Demir, Director, Digital Strategy Novartis

Adaptive Measurement
Matt Walsh, Senior Director, Solutions Engineering, Crossix

How to Innovate During Uncertain Times
Dr. Gautam Gulati

What Physicians Need Now – Latest Research
Heath Morlok, Sr. Director, Market Value & Impact, Everyday Health Professional

DAY TWO

October 1st
12:00 – 1:30pm edt

WELCOME (DHC + Novartis)

Social Media Case Study
Brad Carlson, Digital Strategist, Novartis
Mike Edwards, Brand Manager, Adakveo, Novartis

The Realist’s Guide to Social Marketing During Chaotic Times
Brad Einarsen, Sr. Director, Social Media, Klick Health

5G Innovation – The Impact on the Healthcare Experience
Mark Pappas, SVP, Innovation, CMI/Compas
Dan Roman, Managing Partner, Verizon

Insight into Shifting Consumer Health Behaviors
Alyssa Kopelman, Sr. Manager, Healthline

Closing Fireside Chat
Mark Bard, DHC Co-Founder
Belen Fraile, VP & Head, US Oncology Strategic Data & Digital, Novartis Oncology

Contact Us

christine franklin

CHRISTINE FRANKLIN
Executive Director
DHC Group
[email protected]

MARK BARD
Co-Founder
DHC Group
[email protected]